UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PP050-MON: Muscle Weakness, Osteopenia and Disturbed Metabolic Activity in Patients with Cirrhosis and Ascites

Clinical nutrition (Edinburgh, Scotland), 2014-09, Vol.33, p.S148-S148

2014

Volltextzugriff (PDF)

Deficiency of 25-hydroxyvitamin D3 in a department of gastroenterology. A descriptive cross-sectional study

Bone (New York, N.Y.), 2009-06, Vol.44, p.S365-S365

2009

Volltextzugriff (PDF)

PP076-MON NUTRITIONAL FACTORS AND BONE METABOLISM IN PATIENTS WITH ALCOHOL DEPENDENCE

Clinical nutrition. Supplements, 2012-09, Vol.7 (1), p.168-168

2012

Volltextzugriff (PDF)

Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases

Scandinavian journal of gastroenterology, 2015-01, Vol.50 (10), p.1191-1198

2015

Volltextzugriff (PDF)

O037 POSSIBLE INTERACTIONS BETWEEN DIETARY FIBRES AND 5-AMINOSALICYLIC ACID (5-ASA)

Clinical nutrition. Supplements, 2009, Vol.4 (2), p.18-18

2009

Volltextzugriff (PDF)

Biologic therapy in inflammatory bowel disease

Danish medical journal, 2013-06, Vol.60 (6), p.B4652

2013

Volltextzugriff (PDF)

DOP03 The use and efficacy of biological therapies 2010–2020 for Inflammatory Bowel Disease in a Danish tertiary centre

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i053-i054

2022

Volltextzugriff (PDF)

P209 - A randomised controlled trial with Probio-Tec AB-25 for maintenance of remission in ulcerative colitis

Journal of Crohn's and colitis, 2009-02, Vol.3 (1), p.S93-S93

2009

Volltextzugriff (PDF)

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis

Inflammatory bowel diseases, 2016-05, Vol.22 (5), p.1042-1048

2016

Volltextzugriff (PDF)

Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial

Scandinavian journal of gastroenterology, 2019-02, Vol.54 (2), p.188-193

2019

Volltextzugriff (PDF)

Prednisolone treatment affects the performance of the QuantiFERON gold in‐tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection

Inflammatory bowel diseases, 2011-11, Vol.17 (11), p.2340-2349

2011

Volltextzugriff (PDF)

The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients

Journal of Crohn's and colitis, 2015-08, Vol.9 (8), p.625-632

2015

Volltextzugriff (PDF)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease

Frontiers in medicine, 2018-11, Vol.5, p.304-304

2018

Volltextzugriff (PDF)

S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery

Obesity facts, 2017, Vol.10 (4), p.386-395

2017

Volltextzugriff (PDF)

Probiotic treatment of collagenous colitis: A randomized, double‐blind, placebo‐controlled trial with lactobacillus acidophilus and bifidobacterium animalis subsp. lactis

Inflammatory bowel diseases, 2006-05, Vol.12 (5), p.395-401

2006

Volltextzugriff (PDF)

Possible interactions between dietary fibres and 5-aminosalicyclic acid

Therapeutic advances in gastroenterology, 2010-01, Vol.3 (1), p.5-9

2010

Volltextzugriff (PDF)

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis

Clinical gastroenterology and hepatology, 2015-11, Vol.13 (11), p.1929-1936.e1

2015

Volltextzugriff (PDF)

Challenges and obstacles in the transition process through the eyes of the gastroenterologist

European journal of gastroenterology & hepatology, 2019-04, Vol.31 (4), p.486-493

2019

Volltextzugriff (PDF)

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial

Journal of Crohn's and colitis, 2014-11, Vol.8 (11), p.1498-1505

2014

Volltextzugriff (PDF)

Tu1715 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL ON EFFICACY AND SAFETY OF PROBIOTIC TREATMENT WITH TRICHURIS SUIS OVA IN PATIENTS WITH ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1090-S-1091

2023

Volltextzugriff (PDF)

Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites

Scandinavian journal of gastroenterology, 2016-05, Vol.51 (5), p.601-609

2016

Volltextzugriff (PDF)

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis

Scientific reports, 2016-09, Vol.6 (1), p.31152-31152, Article 31152

2016

Volltextzugriff (PDF)

Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection

Scandinavian journal of gastroenterology, 2013-05, Vol.48 (5), p.638-639

2013

Volltextzugriff (PDF)

The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment

Scandinavian journal of gastroenterology, 2014-04, Vol.49 (4), p.418-423

2014

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(43)

Sprache

Englisch
(41)
Dänisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PP050-MON: Muscle Weakness, Osteopenia and Disturbed Metabolic Activity in Patients with Cirrhosis and Ascites

Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Deficiency of 25-hydroxyvitamin D3 in a department of gastroenterology. A descriptive cross-sectional study

PP076-MON NUTRITIONAL FACTORS AND BONE METABOLISM IN PATIENTS WITH ALCOHOL DEPENDENCE

Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases

O037 POSSIBLE INTERACTIONS BETWEEN DIETARY FIBRES AND 5-AMINOSALICYLIC ACID (5-ASA)

Biologic therapy in inflammatory bowel disease

DOP03 The use and efficacy of biological therapies 2010–2020 for Inflammatory Bowel Disease in a Danish tertiary centre

P209 - A randomised controlled trial with Probio-Tec AB-25 for maintenance of remission in ulcerative colitis

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis

Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial

Prednisolone treatment affects the performance of the QuantiFERON gold in‐tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection

The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease

S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery

Probiotic treatment of collagenous colitis: A randomized, double‐blind, placebo‐controlled trial with lactobacillus acidophilus and bifidobacterium animalis subsp. lactis

Possible interactions between dietary fibres and 5-aminosalicyclic acid

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis

Challenges and obstacles in the transition process through the eyes of the gastroenterologist

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial

Tu1715 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL ON EFFICACY AND SAFETY OF PROBIOTIC TREATMENT WITH TRICHURIS SUIS OVA IN PATIENTS WITH ULCERATIVE COLITIS

Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis

Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection

The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment

Suchergebnisse filtern